Showing results (821-830 of 1,025) with videos related to
Sort By:
Pageof 103
American Journal of Preventive Medicine|December 20, 2017
Update on the Methods of the U.S. Preventive Services Task Force: Linking Intermediate Outcomes and Health Outcomes in PreventionTracy A Wolff, Alex H Krist, Michael LeFevre, et al.The American Journal of Pathology|September 1, 2009
Platelet-derived growth factor receptor expression and activation in choroid plexus tumorsBjörn Koos, Janna Paulsson, Malin Jarvius, et al.Southern Medical Journal|June 14, 2014
HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women)Joann M Schulte, Abbie R Bellamy, Edward W Hook, et al.Seminars in Oncology|August 18, 2001
Combining gemcitabine with radiation in pancreatic cancer: understanding important variables influencing the therapeutic indexC H Crane, R A Wolff, J L Abbruzzese, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|December 9, 2004
Pancreaticoduodenectomy with vascular resection: margin status and survival durationJennifer F Tseng, Chandrajit P Raut, Jeffrey E Lee, et al.Journal of the American College of Surgeons|February 28, 2007
Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?Thomas A Aloia, Thomas E Aloia, Jeffrey E Lee, et al.Annals of Surgical Oncology|May 29, 2009
Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin CLaura A Lambert, Terri S Armstrong, J Jack Lee, et al.Cancer|July 27, 2004
Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinomaYehuda Z Patt, Manal M Hassan, Alvaro Aguayo, et al.The American Journal of Surgical Pathology|January 4, 2013
Frequency of HER-2 positivity in rectal cancer and prognosisLena-Christin Conradi, Hanna Styczen, Thilo Sprenger, et al.Journal of Cardiovascular Pharmacology and Therapeutics|October 5, 2001
Electrophysiologic effects of a novel selective adenosine A1 agonist (CVT-510) on atrioventricular nodal conduction in humansB B Lerman, K A Ellenbogen, A Kadish, et al.Pageof 103